Centre Testing International Group (300012) Q2 2025 earnings summary

Executive summary

• Achieved revenue of ¥2.96 billion, up 6.05% year-over-year for H1 2025; net profit attributable to shareholders rose 7.03% to ¥467 million; adjusted net profit (excluding non-recurring items) increased 9.08%.

• Operating cash flow surged 686.93% year-over-year to ¥175 million, reflecting improved collections and cash management.

• Maintained strategic focus on core business, digital transformation, and international expansion, with several strategic acquisitions completed.

Financial highlights

• EBITDA reached ¥796 million, up 4.39% year-over-year.

• Gross margin and profitability improved across key business segments, with overall net margin and EPS both increasing.

• Total assets at period-end were ¥9.45 billion, stable from year-end 2024; net assets attributable to shareholders rose 4.39% to ¥7.22 billion.

• Non-recurring gains totaled ¥27.9 million, mainly from government subsidies and investment returns.

Outlook and guidance

• Management expects continued growth driven by digitalization, internationalization, and expansion in high-value sectors such as life sciences, semiconductors, and ESG services.

• Ongoing focus on operational efficiency, lean management, and talent development to support sustainable growth.